Effectiveness of a Multicomponent Quality Improvement Strategy to Improve Achievement of Diabetes Care Goals

• DOI: 10.7326/m15-2807
• Publication Date: 2016-07-11T23:44:37Z
• Authors: Mohammed K. Ali; Kavita Singh; Dimple Kondal; Raji Devarajan; Shivani A. Patel; Roopa Shivashankar; Vamadevan S. Ajay; A.G. Unnikrishnan; V. Usha Menon; Premlata K. Varth...; Vijay Viswanathan; Mala Dharmalingam; Ganapati Bantwal; Rakesh Kumar Sahay; Muhammad Qamar Ma...; Rajesh Khadgawat; Ankush Desai; Bipin Sethi; Dorairaj Prabhakaran; K.M. Venkat Narayan; Nikhil Tandon
• Keywords: Glycated Hemoglobin; Male; Patient Care Team; India; Blood Pressure; Cholesterol, LDL; Middle Aged; Decision Support Systems, Clinical; 16. Peace & justice; Quality Improvement; 01 natural sciences; 3. Good health; Treatment Outcome; Diabetes Mellitus, Type 2; Risk Factors; Quality of Life; Electronic Health Records; Humans; Female; Pakistan; 0101 mathematics; Follow-Up Studies

Achievement of diabetes care goals is suboptimal globally. Diabetes-focused quality improvement (QI) is effective but remains untested in South Asia.To compare the effect of a multicomponent QI strategy versus usual care on cardiometabolic profiles in patients with poorly controlled diabetes.Parallel, open-label, pragmatic randomized, controlled trial. (ClinicalTrials.gov: NCT01212328).Diabetes clinics in India and Pakistan.1146 patients (575 in the intervention group and 571 in the usual care group) with type 2 diabetes and poor cardiometabolic profiles (glycated hemoglobin [HbA1c] level ≥8% plus systolic blood pressure [BP] ≥140 mm Hg and/or low-density lipoprotein cholesterol [LDLc] level ≥130 mg/dL).Multicomponent QI strategy comprising nonphysician care coordinators and decision-support electronic health records.Proportions achieving HbA1c level less than 7% plus BP less than 130/80 mm Hg and/or LDLc level less than 100 mg/dL (primary outcome); mean risk factor reductions, health-related quality of life (HRQL), and treatment satisfaction (secondary outcomes).Baseline characteristics were similar between groups. Median diabetes duration was 7.0 years; 6.8% and 39.4% of participants had preexisting cardiovascular and microvascular disease, respectively; mean HbA1c level was 9.9%; mean BP was 143.3/81.7 mm Hg; and mean LDLc level was 122.4 mg/dL. Over a median of 28 months, a greater percentage of intervention participants achieved the primary outcome (18.2% vs. 8.1%; relative risk, 2.24 [95% CI, 1.71 to 2.92]). Compared with usual care, intervention participants achieved larger reductions in HbA1c level (-0.50% [CI, -0.69% to -0.32%]), systolic BP (-4.04 mm Hg [CI, -5.85 to -2.22 mm Hg]), diastolic BP (-2.03 mm Hg [CI, -3.00 to -1.05 mm Hg]), and LDLc level (-7.86 mg/dL [CI, -10.90 to -4.81 mg/dL]) and reported higher HRQL and treatment satisfaction.Findings were confined to urban specialist diabetes clinics.Multicomponent QI improves achievement of diabetes care goals, even in resource-challenged clinics.National Heart, Lung, and Blood Institute and UnitedHealth Group.